Subscribe
Close Sidebar
Politics
States
Economy
Society
Business
Culture
Infra
Defence
World
Books
Ideas
Science
Technology
Heritage
Archives
Legal
Movies
Sports
Subscribe
Sign In
Our Views
Politics
States
Economy
Society
Business
Culture
Infra
Defence
World
Books
Ideas
Science
Technology
Heritage
Archives
Legal
Movies
Sports
Magazine
Store
J%26J
Johnson & Johnson Announces Separation Of Businesses: Details You Need To Know
Bhaswati Guha Majumder
2yr
News Brief
J&J Seeks Approval For Clinical Trials Of Its Single-Shot COVID-19 Vaccine On Adolescents Aged 12-17 Years In India
Swarajya Staff
2yr
Insta
J&J's Single-Shot COVID-19 Vaccine Becomes Fifth Jab To Get Approval For Emergency Use In India
Swarajya Staff
2yr
Insta
US Pharma Major J&J Seeks Emergency Use Approval For Its Single-Shot COVID-19 Vaccine In India
Swarajya Staff
2yr
Insta
AHPI Close To Striking A Deal For Import Of J&J's Single-Dose COVID-19 Vaccine Into India Early Next Month
Swarajya Staff
2yr
Insta
Bullish Scenario For Vaccine Rollout: How India Might Achieve Herd Immunity By Dussehra
Swarajya Staff
3yr
Science
Covid-19 Vaccine Could Be Ready By October End, Claims Pharma Major Pfizer’s CEO
IANS
4yr
Insta
Double Trouble For Johnson & Johnson: After Asbestos Panic, Now It’s Faulty Hip Transplants
Swarajya Staff
5yr
Insta
Load More
Get Swarajya in your inbox.
Subscribe